Lecture Presentation
Back to course
Video Transcription
Video Summary
clozapine underutilization
FDA-approved medication
treatment-resistant schizophrenia
barriers to clozapine utilization
hematologic monitoring device
multidisciplinary clozapine clinics
clozapine hotline
improving clozapine utilization
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
Powered By